After obtaining his Ph.D. in Cardiovascular Physiology in 2001, Roger Legtenberg started his career in Life Sciences. Until 2009 he held Project Manager, Clinical Research Manager and Director Business Development positions.
From 2010 until the end of 2018, he was co-owner and CEO of PSR Orphan Experts, a specialized clinical CRO focused on rare diseases. He successfully led the organizational transformation finding it’s true purpose and utilizing Lean & How (Golden Circle) principles. Under his leadership, significant growth in staff, finances and most importantly impact for the rare disease community was achieved. In 2017 PSR was acquired by Ergomed plc.
Roger is a recipient of the 2018 CEO Today Europe & 2018 International Life Sciences GHP Drug Development CEO awards. He also previously served as a board member of ACRON and BioFarmind (now HollandBio).
Roger strongly believes that a change in business eco-system is required in order to address one of the most important challenges for the Life Sciences industry: the sustainability & society acceptance of development of new treatments for patients.
On this premise, Roger founded Up Strong early 2019 to passionately facilitate companies and all other stakeholders in the industry with their (upcoming) challenges on Training & Coaching, Business Strategy and (Interim-) Management with a clear focus on the human side of the Drug Development Cycle.
Currently, Roger holds a CEO a.i. position at BiosparQ, an in vitro diagnostics company dedicated to provide healthcare professionals with a unique solution for rapid diagnostics of infectious diseases, and a CBO position at Immunetune, a pioneering biotech company developing personalized DNA-based vaccines (NeoVAC) against cancer.